BAGADILICO

Faculty of Medicine | Lund University

Menu

BAGADILICO – Excellence in Parkinson and Huntington Research

Parkinson’s disease and Huntington’s disease are caused by the death of nerve cells in the part of the brain called basal ganglia.

Our goal is to develop and improve treatments for the diseases and to improve quality of life for patients and their families.

News

Is it possible to convert a patient’s own skin cells into functioning nerve cells? Or insert healthy genes to reprogram the cells of a damaged brain? Stem cell researcher Malin Parmar at Lund University in Sweden is studying these types of issues, in close collaboration with clinical researchers. She is now awarded a prize of SEK 100 000 from the Eric K. Fernström Foundation for her work.

A group of about 40 Parkinson´s patients and family members got to experience a captivating study visit at BMC on September 7th. The event was organised by Bagadilico, under the leadership of Professor Angela Cenci Nilsson. Read more about the event on Parkinson Skåne´s website (in Swedish).

On September 7th, BAGDILICO invites the patient organisation Parkinson Skåne to a half-day study visit at the Biomedical Center (BMC). The event is organised by researchers associated with BAGADILICO and will consist of a series of short presentations, followed by guided tours to several research labs at BMC.

Researchers at Lund University have used a completely new preclinical technique and analysis of tissue from patients to show exactly what happens when certain patients with Parkinson’s disease are restored as a result of nerve cell transplants. They have also identified what makes many of the transplant patients develop serious side effects in the form of involuntary movements.

In the late 1980s and over the 1990s, researchers at Lund University in Sweden pioneered the transplantation of new nerve cells into the brains of patients with Parkinson’s disease. The outcomes proved for the first time that transplanted nerve cells can survive and function in the diseased human brain. Some patients showed marked improvement after the transplantation while others showed moderate or no relief of symptoms. A small number of patients suffered unwanted side-effects in the form of involuntary movements.

Site overview